Analysis of apoptotic related gene in malignant glioma and development of the gene therapy
Analysis of apoptotic related gene in malignant glioma and development of the gene therapy
批准号:
11671376
负责人:
SOGAWA Noriaki
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
From the analysis of Apoptosis relation gene (bax, bcl-2, bcl-xl), it was discovered that the expression of abnormal EGFR was related to the expression of bcl-xl. The result using these experimental models got the similar result from the research using our operation cases. The tumor proliferation capability (the MIB-1 positive rate) was high in malignant glioma over expressing abnormal EGFR, and it was clinically discovered that it tended to suppress apoptosis and tended to also over express bcl-XL. However, there were the cases in which apoptosis occurred in spite of over expression of bcl-xl in the operation cases. In such case, the expression of bax has been recognized. The appearance of apoptosis was related to the ratio of bax/bcl-XL in malignant glioma. Bcl-XL in apoptosis of malignant glioma, it was made to be an inhibitor, and bax was related as an induction gene. It was found that abnormal EGFR was related the expression of bcl-XL. We analyzed the expression of bax and mutation type of p53 in the sixty operation cases. In the result, there was a tendency of the way which anticipated the relationship between p53 and bax. In short, wild type p53 makes the bax expression promote, and mutant type p53 does suppress the bax expression. Then, we insert exogenous p53 gene or p130 gene in four kinds of gene recombination cell line. Then, we examined the expression of p53 family and bax in vitro. However, we could not have the results of the relationship between p53 family and bax, which we expected. From these results, we could estimate that p53 family send a signal via a new gene to bax. But, we could not determine this new gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Uniformization of Annual Maximum 1・2・3 Day Precipitations and its Nonstationary Frequency Analysis
-
批准号:08650595
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:SOGAWA Noriaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: